Page 202 - Read Online
P. 202

Molinari et al. Hepatoma Res 2018;4:56  I  http://dx.doi.org/10.20517/2394-5079.2018.71                                          Page 11 of 15


                                                  Overall survival stratified by ethnicity











                          Legeng: recipient ethnicity





















                                                         Time (years)

                                      Time after liver transplantation (years)
               N. patients at risk    0              1          2         3           4          5
               African Americans      531            395        275       202         142        89
               Caucasians             4,054          3,124      2,329     1,790       1,295      922
               Hispanics              859            669        509       382         295        196
               Asians                 522            416        333       274         215        161
               Multiracial or other minorities   82   66        52        40          32         25

               Figure 3. Kaplan-Meier survival functions of patients undergoing liver transplantation for hepatocellular carcinoma in the United States
               stratified by ethnicity. The probability of 5-year survival was 81% for patients belonging to multiracial or other minorities, 79% for Asians,
               73% for Hispanics, 68% for Caucasians and 56% for African American (P ≤ 0.001)


               Patients who undergo LT are only a fraction of the number of patients who are referred but fail selection due
               to insufficient social support, inability to travel to transplant centers or lack of resources including health-
               care insurance. And, since most of the transplant centers in the United States use comparable criteria for
               screening patients with inadequate socio-economic resources, and use the Milan criteria for staging HCC
               irrespective of patient ethnicity, we advanced the hypothesis that unless there were biological reasons, there
               should not be significant ethnic differences in outcomes after LT.


               Overall the results of this study are not novel, yet there are several methodological differences that
               distinguish our study from others. First of all, we included only patients who had documented HCC in
               their explanted livers. Confirmation that all recipients in this study had HCC is important because up to
               11% of patients who are diagnosed with HCC by imaging tests without biopsy prior to LT end up having no
                                                                       [52]
               pathological evidence of neoplastic lesions in their explanted livers . Second, before we analyzed the long-
               term outcomes, we confirmed that there were no significant differences in perioperative mortality between
               African Americans and other ethnic groups. Proving that the risk of death at 30-, 60-, and 90-day after LT
               was similar between the two groups supported the concept that there were no fundamental differences in
   197   198   199   200   201   202   203   204   205   206   207